Current and Emerging Systemic Therapies for Renal Cell Carcinoma: Clinical Evidence and Guideline Recommendations

Get up to date on multidisciplinary management of renal cell carcinoma with downloadable slides and an on-demand webcast plus an expert commentary from a live webinar on the most important data from ASCO GU 2022.

Share

Program Content

Activities

RCC: Adjuvant Approaches and First-Line Therapy for Advanced Disease
Considerations for Selecting Systemic Therapy for Patients with RCC: Adjuvant Approaches and First-Line Therapy for Advanced Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

RCC: Second-Line Therapy and Beyond
Optimal Treatment for Patients With Progressive RCC After 1 or More Previous Lines of Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

RCC: Managing AEs
Optimal Management of Immune-Related Adverse Events for Patients With Advanced RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

Activities

FAQ: Adjuvant Tx for RCC
Experts Answer HCP Questions on Adjuvant Therapy for Renal Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2022

Expires: April 12, 2023

FAQ: Tx for Metastatic RCC
Experts Answer HCP Questions on Therapy for Metastatic Renal Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2022

Expires: April 12, 2023

Faculty

cover img faculity

Brian A. Costello, MD, MS

Associate Professor of Oncology and Urology
Consultant

Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Eric Jonasch, MD

Assistant Professor, Genitourinary Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Exelixis, Inc.

Merck Sharp & Dohme Corp.

Pfizer, Inc.